SEC Form 4 · accession 0001127602-17-032220
LEXICON PHARMACEUTICALS, INC. · LXRX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Lonnel Coats
Officer — President and CEO · Director
Period of report
Nov 15, 2017
Accepted (ET)
Nov 15, 2017 · 5:15 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001062822
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Nov 15, 2017 | P | 10,000 | $9.91 | A | 42,985 | D |
Table II — derivative securities
No Table II lines on this filing.